Disruption of the Apelin-APJ System Worsens Hypoxia-Induced Pulmonary Hypertension
Authors:
- 1 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 31 (4) , 814-820
Abstract
Objective—: The G-protein–coupled receptor APJ and its ligand apelin are highly expressed in the pulmonary vasculature, but their function in this vascular bed is unclear. We hypothesized that disruption of apelin signaling would lead to worsening of the vascular remodeling associated with pulmonary hypertension (PH). Methods and Results—: We found that apelin-null mice developed more severe PH compared with wild-type mice when exposed to chronic hypoxia. Micro-computed tomography of the pulmonary arteries demonstrated significant pruning of the microvasculature in the apelin-null mice. Apelin-null mice had a significant reduction of serum nitrate levels. This was secondary to downregulation of endothelial nitric oxide synthase (eNOS), which was associated with reduced expression of Kruppel-like factor 2 (KLF2), a known regulator of eNOS expression. In vitro knockdown studies targeting apelin in human pulmonary artery endothelial cells demonstrated decreased eNOS and KLF2 expression, as well as impaired phosphorylation of AMP-activated kinase and eNOS. Moreover, serum apelin levels of patients with PH were significantly lower than those of controls. Conclusion—: These data demonstrate that disruption of apelin signaling can exacerbate PH mediated by decreased activation of AMP-activated kinase and eNOS, and they identify this pathway as a potentially important therapeutic target for treatment of this refractory human disease.Keywords
This publication has 42 references indexed in Scilit:
- Flow Activation of AMP-Activated Protein Kinase in Vascular Endothelium Leads to Krüppel-Like Factor 2 ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Endogenous regulation of cardiovascular function by apelin-APJAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertensionBritish Journal of Pharmacology, 2009
- Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitrationJournal of Clinical Investigation, 2009
- Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosisJournal of Clinical Investigation, 2008
- In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout miceJournal of Experimental Medicine, 2007
- Pathobiology of Pulmonary HypertensionAnnual Review of Pathology: Mechanisms of Disease, 2007
- Deletion of the eNOS gene has a greater impact on the pulmonary circulation of male than female miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Decreased Whole Body Endogenous Nitric Oxide Production in Patients with Primary Pulmonary HypertensionJournal of Vascular Research, 2005